Research reportDecreased dopamine type 2 receptor availability after bariatric surgery: Preliminary findings
Introduction
Bariatric surgery is the most effective treatment for obesity. Successful weight loss due to surgery results in substantial improvement in co-morbidities and decreases mortality (Sjostrom et al., 2007). This is in contrast to available medical therapies which have limited effectiveness (Sjostrom et al., 2004). RYGB is the most common weight loss procedure performed in the United States (Santry et al., 2005). RYGB results in 60% loss of excess weight (Buchwald et al., 2009), and the majority of the weight loss is maintained long term (Sjostrom et al., 2007). Much of the success of RYGB is felt to be due to a rapid reduction in food intake that remains below preoperative levels long term (Sjostrom et al., 2004). Morinigo et al. (2006) reported that at 6 weeks after RYGB, hunger decreases and satiety improves despite ongoing rapid weight loss. The vertical sleeve gastrectomy (VSG) surgical procedure, which results in weight loss and decreased hunger and improved satiety similar to that with RYGB (Karamanakos et al., 2008b), is being performed at increasing rates for advanced obesity (Iannelli et al., 2008). The mechanisms by which these procedures improve hunger and satiety are largely unknown.
Dopaminergic neurotransmission plays a pivotal role in motivating appetitive behaviors and in the reinforcements of food stimuli which drive the desire to eat beyond nutritional requirements (Volkow et al., 2008). Dopamine (DA) underlies the motivation for food intake and rodents mice that do not synthesize DA die of starvation unless DA is restored in the dorsal striatum (Szczypka et al., 2001). Wang et al. used PET imaging with a dopamine type D2/D3 (DA D2) receptor radioligand to measure availability of DA D2 receptors in subjects with extreme obesity (BMI > 40 kg/m2). They demonstrated reduction in DA D2 receptor availability in the striatum (Wang et al., 2001), similar to what they had seen in numerous studies of drug addiction (Volkow et al., 1999). Various animal models support decreased striatal DA D2 receptors in obesity (Hamdi et al., 1992, Huang et al., 2006). Reduced striatal DA D2 receptors in obesity and addiction are felt to cause decreased dopaminergic neurotransmission and sensing of reward, and lead to the compensatory behaviors of increased intake of food or substance of abuse.
We aimed to test the hypothesis that dopaminergic neurotransmission improves in the early months after RYGB and VSG surgery for the treatment of obesity, contributing to higher reward stimuli and improved eating behaviors. Understanding the mechanism of improved appetite after successful bariatric procedures will ultimately support advancement in new therapies for the treatment of obesity.
Section snippets
Results
Five females (46 ± 2 years of age) with baseline weight of 118 ± 6 kg and body mass index (BMI) of 43 ± 3 kg/m2 were studied preoperatively and postoperatively (Table 1). Table 1 details demographic and relevant medical history data. At the postoperative study, the mean weight loss was 14 ± 1 kg, or 12 ± 1% of initial body weight, resulting in significant reduction in BMI to 38 ± 3 kg/m2 (both p = 0.043). The Beck Depression Inventory-II (BDI) was completed preoperatively and postoperatively with mean scores of 2 ±
Discussion
DA D2 receptor availability was decreased at 7 weeks after bariatric surgery in numerous regions relevant for eating behaviors. We interpret the decreased DA D2 receptor availability to represent increased extracellular DA levels competing with the radioligand. The level of decrease in DA D2 receptor availability observed in this study is comparable to other studies where we used pharmacologic agents to increase extracellular DA levels (Riccardi et al., 2006). Wang et al. (2001) revealed that in
Subjects
Protocol approval was obtained from the Vanderbilt University Institutional Review Board and all participants gave written informed consent. Five females (three right handed, two left handed) with preoperative BMI > 35 kg/m2 were recruited from the Vanderbilt Center for Surgical Weight Loss. Participants had to be approved for either RYGB or VSG surgery. All subjects underwent a history and physical exam by study physician including detailed history of substance exposure. Medical records were
Acknowledgments
We would like to thank Pamela Marks-Shulman, M.S., R.D. and Joan Kaiser, R.N. for their hard work in support of this study. J.P.D. received support from the Vanderbilt Environmental Health Science Scholars Program (NIEHS K12 ESO15855). This work was supported by NIH grants RO1-DK070860, NIDDK to N.N.A. This work was also supported in part by Vanderbilt CTSA grant 1 UL1 RR024975 from NCRR/NIH, the Vanderbilt Diabetes Research and Training Center (DK20593), and the Vanderbilt Digestive Diseases
References (51)
- et al.
Sex differences in the rapid and acute effects of estrogen on striatal D2 dopamine receptor binding
Brain Res.
(1994) - et al.
A review of psychosocial outcomes of surgery for morbid obesity
J. Psychosom. Res.
(2002) - et al.
Dopamine D2 receptors in depression measured with single photon emission computed tomography
Biol. Psychiatry
(1994) - et al.
Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat
Brain Res.
(2003) - et al.
The assessment of binge eating severity among obese persons
Addict. Behav.
(1982) - et al.
Dissociation of primary and secondary reward-relevant limbic nuclei in an animal model of relapse
Neuropsychopharmacology
(2000) - et al.
Decreased striatal D2 dopamine receptors in obese Zucker rats: changes during aging
Brain Res.
(1992) - et al.
Leptin receptor signaling in midbrain dopamine neurons regulates feeding
Neuron
(2006) - et al.
Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity
Behav. Brain Res.
(2006) - et al.
Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects
Biol. Psychiatry
(2009)
High-fat diet decreases tyrosine hydroxylase mRNA expression irrespective of obesity susceptibility in mice
Brain Res.
Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride
Biol. Psychiatry
Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers
Neuroimage
Separable substrates for anticipatory and consummatory food chemosensation
Neuron
Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice
Neuron
Brain dopamine and obesity
Lancet
Multi-modal volume registration by maximization of mutual information
Med. Image Anal.
Control of sensorimotor function by dopaminergic nigrostriatal neurons: influence on eating and drinking
Neurosci. Biobehav. Rev.
Bilateral hypothalamic dopamine infusion in male Zucker rat suppresses feeding due to reduced meal size
Pharmacol. Biochem. Behav.
Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients
J. Pers. Assess.
Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis
Am. J. Med.
The role of dopamine in the pathophysiology of depression
Arch. Gen. Psychiatry
Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects
J. Clin. Endocrinol. Metab.
Estrogen-dependent alterations in D2/D3-induced G protein activation in cocaine-sensitized female rats
J. Neurochem.
Insulin, leptin, and food reward: update 2008
Am. J. Physiol. Regul. Integr. Comp. Physiol.
Cited by (132)
Consultation-Liaison Case Conference: Psychiatric Care of Patients Who Undergo Bariatric Surgery
2023, Journal of the Academy of Consultation-Liaison PsychiatryRoux-en-Y gastric bypass increases GABA-A receptor levels in regions of the rat brain involved in object recognition memory and perceptual acuity
2020, Physiology and BehaviorCitation Excerpt :Roux-en-Y gastric bypass surgery (RYGB) is one of the most common surgical procedures used to combat obesity and its comorbidities, and remains one of the most effective treatments for sustained weight loss [40,41].. The surgery restricts the amount of food a patient can consume at a given time by decreasing the size of the stomach and bypassing the duodenum and jejunum of the proximal small intestine, effectively limiting binge eating [14]. While successful in sustaining weight loss, a significant increase in addictive behaviors [6] including gambling [29] and new-onset substance use disorder (SUD), such as misuse of alcohol [5, 15, 25] cigarettes [10], and opioids [25, 36] has been reported post-surgery in some RYGB patients.